ICAN BioCollection
The Biological Resource Center (BRC) ICAN BioCollection
The CRB ICAN BioCollection (formerly Bio ICAN) integrates the activities of sample collection/reception and processing (centrifugation, aliquoting, DNA and RNA extraction, etc.), storage at -20°C, -80°C and -150°C with temperature monitoring and making biological resources available. ICAN BioCollection stores a wide range of biological samples: serum, plasma, buffy coat, adipose tissue (subcutaneous, mesenteric, omental), liver tissue, urine, stool, saliva…
New sample treatments can thus be set up at the user’s request. TeamThe CRB team is made up of :
- Manager: Christelle DAVRINCHE
- Technical team: Houdah ALI KASSIM, Charlotte BABEL, andMargot-Ruse LOUKIBOU-NZOUMBA
- BRC Quality Manager: Abdelhafid ATTAR, quality engineer.
CRB is governed by an Executive Committee (COMEX).Consult the organization chartCertificateThe CRB ICAN BioCollection obtained the double certification ISO 9001 : 2015 and NF S 96-900 : 2011 in December 2019 for the reception, preparation, conservation, provision of biological resources of human origin relating to cardiometabolic diseases and the hosting of biological samples. This certification was granted by the Euro-quality system certification body in November 2019. This is the result of a quality approach initiated many years ago and testifies to the willingness of CRB ICAN BioCollection to continuously improve the quality of its services in order to guarantee the satisfaction of its stakeholders.
BenefitsOpening hours: 8:30am – 4:30pm, Monday to FridayDirect debit management
- Preparation of sampling kits
- Receipt of direct debits
- Sample management: serum, plasma, PBMC, circulating and cellular DNA and RNA extraction, urine
- Stool aliquoting
- Non-invasive labeling of samples (use of QR-code tube)
- Inventory
Return of biological samples
- Preparation of samples for shipment
- Transport organization
Storage of biological samples
- Storage temperature variable according to needs: – 20°C, – 80°C, -150°C
- Temperature tracking report
- Collection duplication (two levels of separation between two freezers; separation between two storage sites)
- Storage capacity: 1 million samples
- An on-call system is in operation on Saturdays, Sundays and public holidays from 8am to 9pm.
These services are supported by the expertise of Christelle DAVRINCHE. IHU ICAN offers many other services through its scientific platforms and clinical platform.Discover our scientific platformsPolitical qualityThe quality policy is a requirement of the NF S96-900:2011 and ISO 9001:2015 standards. It sets out the quality guidelines laid down by management in line with the ICAN HCI’s strategy. It is the reference allowing to direct the quality approach.
La politique Qualité est consultable ici : Quality Policy – CRB ICAN BioCollectionQuality ManualOur Quality Manual is a document describing the Quality Management System (QMS) of our CRB. It defines the organization of our structure meeting the scope of the dual certification NF S96-900 and ISO 9001, describes the processes and establishes the list of our procedures.Terms of cooperationAs part of its collaborative efforts, the CRB has drafted a Chart which governs the relationship between ICAN BioCollection and its Interested Parties. in compliance with the ethical principles governing the collection of elements and products of the human body and their derivatives, with the legislative and regulatory provisions governing the collection, processing and storage of these products, and with the information associated with them.
In order to optimize the use of the Collections and samples currently deposited and to be deposited in the future, ICAN BioCollection has drawn up this charter, the terms of which are binding on all persons accessing ICAN BioCollection services.
The Bio-ICAN Charter is available here : CRB ICAN BioCollection Charter
Reproduction and use without permission prohibited. Legal authorization
- The bank declared its activity to the Ministry in charge of Research under the number DC – 2013 – 1971, dated 26/07/2014
- The bank has declared compliance with MR004 (2204190 v 0).
Key figuresScientific cohortsPhase II and III clinical studiesDirect debits received each yearSamples prepared each yearSamples made available each year
Our collections catalog
In this table you will find the available biological sample collections.
If you are interested in our Biological Resources, or for the establishment of a collection of Biological Resources within the CRB, you can contact the CRB by CRB.Bio-ICAN@ihuican.org or fill out our request forms below.collectionApproachpathologyAcute Coronary Syndromesample(s)Serum, plasma, DNA, urine, stoolResponsibleProf. Johanne SILVAINstarted in2015SummaryAcute Coronary Syndrome (ACS) is the obstruction of one or more coronary arteries. The objective of this study is to better understand the etiology and pathophysiology of acute coronary syndrome. The APPROACH collection was created in 2015 by Pr. Johanne SILVAIN PU-PH within the Cardiology Department of the Pitié Salpêtrière – Charles Foix University Hospitals, and is made up of serum, plasma, urine, stool and DNA samples with numerous associated clinical data.collectionMyocardiumpathologyHeart failure / cardiomyopathysample(s)Serum, plasma, DNA, urine, stoolResponsibleProf. Richard ISNARDstarted in2015SummaryThe purpose of this study is to monitor patients suffering from heart failure syndrome or cardiomyopathy (CMD). The syndrome is heterogeneous and one of the objectives of this project is to highlight or validate new diagnostic and prognostic biomarkers. The MYOCARD collection was created in 2015 by Pr. Philippe Charron PU-PH within the Cardiology Department of the Pitié Salpêtrière – Charles Foix University Hospitals, and is made up of serum, plasma, urine, stool and DNA samples with numerous associated clinical data.collectioniPS-CARDIOGENpathologyHereditary Heart Diseases (cardiomyopathies/electrical diseases)/hereditary vascular diseasessample(s)Serum, DNA, PBMC, Skin fibroblastsResponsibleProf. Philippe CHARRONstarted in2015SummaryThe mechanisms related to human hereditary heart or vascular diseases remain largely unknown. The objective of the iPS-CARDIOGEN study is to develop new experimental models to study hereditary heart and vascular diseases. The iPS-CARDIOGEN collection was created in 2015 by Pr. Philippe Charron, PU-PH within the Reference Center for Cardiac Diseases of the Pitié Salpêtrière – Charles Foix University Hospitals, and is made up of serum and DNA samples with numerous associated clinical data. Link to relevant study:
http://www.cardiogen.aphp.fr/upload/presentation_ips_cardiogen.pdfcollectionFIFA/EPOS/LITMUSpathologyMetabolic steatosis of the liversample(s)Blood, plasma, urine, liver biopsyResponsibleProf. Vlad RATZIUstarted in2015SummaryMetabolic fatty liver is a chronic liver disease associated with the presence of one or more metabolic risk factors or sleep apnea syndrome, in the absence of another cause of chronic liver disease. Metabolic steatosis can progress to liver fibrosis and cirrhosis. The main research axes of the study related to the collection are the understanding of the physiopathology of metabolic steatosis of the liver and the development of diagnostic tools. The FIFA-EPOS collection was created in 2015 by Pr. Vlad Ratziu, PU-PH in the Hepato-gastro-enterology department of the Pitié Salpêtrière – Charles Foix University Hospitals, and consists of serum and DNA samples with numerous associated clinical data. Link to relevant study:
http://www.epos-nafld.eu/
https://cordis.europa.eu/project/rcn/193284/factsheet/en
https://litmus-project.eu/
https://cordis.europa.eu/project/id/777377/frcollectionFH-CALCpathologyHeterozygous autosomal dominant familial hypercholesterolemiasample(s)Serum, Plasma, stoolResponsibleDr. Antonio Gallostarted in2018SummaryFamilial hypercholesterolemia is an inherited metabolic disorder characterized by elevated LDL cholesterol in the blood. The main lines of research of the FH-CALC study are the understanding of the pathophysiology of familial hypercholesterolemia and the development of diagnostic tools. The FH-CALC collection was created in 2018 by Dr. Antonio Gallo, Associate Practitioner, Internist at the Cardiovascular Disease Prevention Unit of the Cardiology and Metabolism Center of the Pitié Salpêtrière – Charles Foix University Hospitals and is made up of serum, plasma and stool samples. Numerous clinical data are associated with the samples.collectionCORO NASHpathologyMetabolic fatty liver/cardiovascular diseasesample(s)DNA, serum, stool, liver biopsyResponsibleDr. Raluca Paisstarted in2018SummaryThe relationship between metabolic fatty liver disease (NAFLD), metabolic steatohepatitis of the liver (NASH) and atherosclerotic coronary artery disease (MC-ATS) is now recognized due to common cardiometabolic risk factors (FRMs), the likely role of NAFLD/NASH in the occurrence of pre-atherosclerotic lesions and myocardial dysfunction associated with NAFLD/NASH. The aim of this study is to determine the prevalence of NAFLD/NASH in patients admitted to cardiology with suspected coronary disease. The CORO-NASH collection was created in 2019 by Dr. Raluca Pais within the Hepato-Gastroenterology Department of the Pitié Salpêtrière – Charles Foix University Hospitals, and is made up of DNA, serum, stool, liver biopsy samples with numerous associated clinical data.collectionObecopathologyObesitysample(s)SerumResponsibleProf. Anne Bachelotstarted in2018SummaryThe effectiveness of oral contraceptives depends on blood levels of these drugs after digestive absorption and their distribution in the body. Surgeries for obesity with malabsorption (gastric bypass) can in theory alter the biological availability of drugs in obese patients. The aim of this study is to evaluate the pharmacokinetics of oral contraceptives in obese women before and after bariatric surgery. The OBECO collection was created in 2015 by Pr. Anne Bachelot, Pu-PH in the Endocrinology and Reproductive Medicine Department of the Pitié Salpêtrière – Charles Foix University Hospitals, and is made up of serum samples with numerous clinical data associated with the samples.collectionCARDIO-METpathologyFamilial hypercholesterolemiasample(s)Serum, plasmaResponsibleProfessor Eric BRUCKERTstarted in2021SummaryThe crucial role of dyslipidemia, particularly hypercholesterolemia, in the development of cardiovascular disease is particularly well documented. Familial hypercholesterolemia (FH) is a genetic disease characterized by elevated plasma concentrations of LDLC. Lipoproteins rich in triglycerides (TRL), contribute to the progression of cardiovascular diseases. The aim of this study is to compare the apolipoproteic profile of patients with HF by comparing those with associated hyperTG with those with isolated hypercholesterolemia. The CARDIO-MET collection was created in 2021 by Pr Eric BRUCKERT within the Endocrinology and Metabolism Department of the Pitié Salpêtrière – Charles Foix University Hospitals, and consists of serum and plasma samples with associated clinical data.collectionIMPULSMACSpathologyHeart failuresample(s)Serum, DNA, circulating RNA, PBMCResponsibleDr Guillaume Lebretonstarted in2021SummaryThe implantation of LVAD (Left Ventricular Assist Device) constitutes a medium to long-term therapeutic option for patients with end-stage heart failure with isolated left ventricular dysfunction. However, their use remains limited by the frequency of their side effects, which are mostly unpredictable. Several factors, including pulsatility, have been associated with LVAD complications in the literature, including bleeding complications. However, the pathophysiological pathways associated with decreased pulsatility are poorly understood. The prospective follow-up of the patients included in this study aims to study the pathophysiological pathways associated with the reduction in pulsatility and leading to complications of LVAD. The IMPULSMACS collection was created in 2021 by Dr Guillaume Lebreton in the Cardiac Surgery Department of the Pitié Salpêtrière University Hospitals – Charles Foix, and consists of samples of serum, DNA, circulating RNA, PBMC with associated clinical data. Link to relevant study: https://clinicaltrials.gov/ct2/show/NCT04951999
Pricing of services
benefitsICAN/SU (€/unit)Academic (excluding SU) & IndustrialReceipt of sample tubesReception7 €CRI gridFreezing (without technicage)Tube€1CRI gridTechnicagePreparation serum/plasma 2D tube€2.30CRI gridSerum/plasma preparation 2ml tube€2.30CRI gridStool aliquoting€2.50CRI gridTissue preparation for inclusion€2.50CRI gridDNA extraction from blood33 €CRI gridRNA extraction from soft tissue (except adipose tissue)35 €CRI gridPlasma/serum RNA extraction28 €CRI gridSize adipocytes18 €CRI gridTechnician HR time excluding technicage (€/h)28 €CRI gridStep freezing8 €CRI gridPBMC Preparation30 €CRI gridCell count and viability7 €CRI gridFreezing viable cells9 €CRI gridStorage2D tube -80°C€0.05CRI gridTube 2ml -80°C€0.08CRI gridTube 5ml -80°C€0.34CRI gridTube 12ml-15ml -80°C€0.60CRI gridTube 2ml – 150°C€1.05CRI gridDestockingTube€1CRI gridClick here to consult the national price list for CRBs and certified hospital tumor banks established by the Research and Innovation Commission (CRI) of the Conference of General Managers of CHU.Contact(s)Christelle DAVRINCHEOperational Managerc.davrinche@ihuican.orgBuilding E3M – 6th floor
47-48 hospital bd
75013 Paris ICANYou wish…Set up a collection?Fill in the formMake an exit request for biological resources?ContactFeedback via our satisfaction questionnaire?ContactProcessing of your personal data: The processing complies with the provisions of the CNIL (law relating to data processing, files and freedoms as well as the general regulations on data protection). To exercise your rights regarding the processing of your personal data: mesdonnees@ican-institute.orgAre you patient?Download the brochure
